Works matching IS 15228517 AND DT 2025 AND VI 27 AND IP 3

Results: 23
    1
    2
    3

    NCCN CNS Tumor Guidelines Update for 2024.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 3, p. 595, doi. 10.1093/neuonc/noae267
    By:
    • Nabors, Louis Burt;
    • Hattangadi-Gluth, Jona;
    • Horbinski, Craig;
    • Portnow, Jana
    Publication type:
    Article
    4
    5
    6
    7

    Efficacy of 3D-TSE sequence-based radiosurgery in prolonging time to distant intracranial failure: A session-wise analysis in a histology-diverse patient cohort.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 3, p. 854, doi. 10.1093/neuonc/noae232
    By:
    • Akdemir, Eyub Y;
    • Gurdikyan, Selin;
    • Rubens, Muni;
    • Abrams, Kevin J;
    • Sidani, Charif;
    • Chaneles, Margaret C;
    • Hall, Matthew D;
    • Press, Robert H;
    • Wieczorek, D Jay;
    • Tolakanahalli, Ranjini;
    • Gutierrez, Alonso N;
    • Gal, Omer;
    • Rosa, Alonso La;
    • Kutuk, Tugce;
    • McDermott, Michael W;
    • Odia, Yazmin;
    • Mehta, Minesh P;
    • Kotecha, Rupesh
    Publication type:
    Article
    8
    9
    10
    11

    Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 3, p. 767, doi. 10.1093/neuonc/noae234
    By:
    • Strauss, Joshua D;
    • Gilbert, Mark R;
    • Mehta, Minesh;
    • Li, Ang;
    • Zhou, Renke;
    • Bondy, Melissa L;
    • Sulman, Erik P;
    • Yuan, Ying;
    • Liu, Yanhong;
    • Vera, Elizabeth;
    • Wendland, Merideth M;
    • Stieber, Volker W;
    • Puduvalli, Vinay K;
    • Choi, Serah;
    • Martinez, Nina L;
    • Robins, H Ian;
    • Hunter, Grant K;
    • Lin, Chi-Fan;
    • Guedes, Vivian A;
    • Richard, Melissa A
    Publication type:
    Article
    12
    13

    Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 3, p. 828, doi. 10.1093/neuonc/noae229
    By:
    • Takami, Hirokazu;
    • Matsutani, Masao;
    • Suzuki, Tomonari;
    • Takabatake, Kazuhiko;
    • Fujimaki, Takamitsu;
    • Okamoto, Michinari;
    • Yamaguchi, Shigeru;
    • Kanamori, Masayuki;
    • Matsuda, Kenichiro;
    • Sonoda, Yukihiko;
    • Natsumeda, Manabu;
    • Ichinose, Toshiya;
    • Nakada, Mitsutoshi;
    • Muroi, Ai;
    • Ishikawa, Eiichi;
    • Takahashi, Masamichi;
    • Narita, Yoshitaka;
    • Tanaka, Shota;
    • Saito, Nobuhito;
    • Higuchi, Fumi
    Publication type:
    Article
    14

    Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 3, p. 811, doi. 10.1093/neuonc/noae228
    By:
    • Laemmerer, Anna;
    • Lehmann, Christian;
    • Mayr, Lisa;
    • Bruckner, Katharina;
    • Gabler, Lisa;
    • Senfter, Daniel;
    • Meyer, Philipp;
    • Balber, Theresa;
    • Pirker, Christine;
    • Jaunecker, Carola N;
    • Kirchhofer, Dominik;
    • Vician, Petra;
    • Griesser, Michelle;
    • Spiegl-Kreinecker, Sabine;
    • Schmook, Maria T;
    • Traub-Weidinger, Tatjana;
    • Kuess, Peter;
    • Eckert, Franziska;
    • Federico, Aniello;
    • Madlener, Sibylle
    Publication type:
    Article
    15

    Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 3, p. 616, doi. 10.1093/neuonc/noae235
    By:
    • Lucas, Calixto-Hope G;
    • Gross, Andrea M;
    • Romo, Carlos G;
    • Dehner, Carina A;
    • Lazar, Alexander J;
    • Miettinen, Markku;
    • Pekmezci, Melike;
    • Quezado, Martha;
    • Rodriguez, Fausto J;
    • Stemmer-Rachamimov, Anat;
    • Viskochil, David;
    • Perry, Arie;
    • Members, the Symposium on Atypical Neurofibroma: State of the Science
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Targeted delivery of napabucasin with radiotherapy improves outcomes in diffuse midline glioma.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 3, p. 795, doi. 10.1093/neuonc/noae215
    By:
    • Gallitto, Matthew;
    • Zhang, Xu;
    • Santos, Genesis De Los;
    • Wei, Hong-Jian;
    • Fernández, Ester Calvo;
    • Duan, Shoufu;
    • Sedor, Geoffrey;
    • Yoh, Nina;
    • Kokossis, Danae;
    • Angel, J Carlos;
    • Wang, Yi-Fang;
    • White, Erin;
    • Kinslow, Connor J;
    • Berg, Xander;
    • Tomassoni, Lorenzo;
    • Zandkarimi, Fereshteh;
    • Chio, Iok In Christine;
    • Canoll, Peter;
    • Bruce, Jeffrey N;
    • Feldstein, Neil A
    Publication type:
    Article
    22
    23